These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 10796882)

  • 1. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
    Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
    Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
    Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
    J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genome-wide loss of heterozygosity analyses in primary hepatocellular carcinoma].
    Li S; Wang H; Zhang C
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):577-81. PubMed ID: 11798820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
    Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
    Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive allelotyping of human intrahepatic cholangiocarcinoma.
    Momoi H; Okabe H; Kamikawa T; Satoh S; Ikai I; Yamamoto M; Nakagawara A; Shimahara Y; Yamaoka Y; Fukumoto M
    Clin Cancer Res; 2001 Sep; 7(9):2648-55. PubMed ID: 11555575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive allelotyping of human hepatocellular carcinoma.
    Nagai H; Pineau P; Tiollais P; Buendia MA; Dejean A
    Oncogene; 1997 Jun; 14(24):2927-33. PubMed ID: 9205099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
    Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
    Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
    Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
    Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping.
    Bluteau O; Beaudoin JC; Pasturaud P; Belghiti J; Franco D; Bioulac-Sage P; Laurent-Puig P; Zucman-Rossi J
    Oncogene; 2002 Feb; 21(8):1225-32. PubMed ID: 11850842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
    Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
    Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelotype of papillary serous peritoneal carcinomas.
    Cass I; Baldwin RL; Fasylova E; Fields AL; Klinger HP; Runowicz CD; Karlan BY
    Gynecol Oncol; 2001 Jul; 82(1):69-76. PubMed ID: 11426964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of somatic heterozygosity in hepatocellular carcinoma.
    Walker GJ; Hayward NK; Falvey S; Cooksley WG
    Cancer Res; 1991 Aug; 51(16):4367-70. PubMed ID: 1678314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
    Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
    Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frequent loss of heterozygosity on chromosome 4 in human hepatocellular carcinoma].
    Li X; Ding M; Lai B
    Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):37-40. PubMed ID: 11798850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma.
    Wong CM; Lee JM; Lau TC; Fan ST; Ng IO
    Clin Cancer Res; 2002 Jul; 8(7):2266-72. PubMed ID: 12114430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Features of micro satellite alterations on chromosome 4 in hepatocellular carcinoma].
    Zhang SH; Cong WM; Xian ZH; Wu MC
    Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):223-6. PubMed ID: 15099473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Loss of heterozygosity on chromosomes 17 and 16 in primary hepatocellular carcinomas].
    Shao J; Li X; Liu Z
    Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):428-30. PubMed ID: 11715437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype.
    Boige V; Laurent-Puig P; Fouchet P; Fléjou JF; Monges G; Bedossa P; Bioulac-Sage P; Capron F; Schmitz A; Olschwang S; Thomas G
    Cancer Res; 1997 May; 57(10):1986-90. PubMed ID: 9157995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelotype study of primary hepatocellular carcinoma.
    Fujimori M; Tokino T; Hino O; Kitagawa T; Imamura T; Okamoto E; Mitsunobu M; Ishikawa T; Nakagama H; Harada H
    Cancer Res; 1991 Jan; 51(1):89-93. PubMed ID: 1670995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.